167 related articles for article (PubMed ID: 30396640)
1. Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography?
Li J; Guo L; Yin L; Fang H; Ye W; Zhao B; Liu Y; Xu T
Eur J Radiol; 2018 Nov; 108():1-6. PubMed ID: 30396640
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Region of Interest Drawing for Quantitative Analysis: Differentiation Between Benign and Malignant Breast Lesions on Contrast-Enhanced Sonography.
Nakata N; Ohta T; Nishioka M; Takeyama H; Toriumi Y; Kato K; Nogi H; Kamio M; Fukuda K
J Ultrasound Med; 2015 Nov; 34(11):1969-76. PubMed ID: 26384607
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
[TBL] [Abstract][Full Text] [Related]
4. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
[TBL] [Abstract][Full Text] [Related]
7. The feasibility of low mechanical index contrast enhanced ultrasound (CEUS) in distinguishing malignant from benign thoracic lesions.
Qureshi NR; Hintze C; Risse F; Kopp-Schneider A; Eberhardt R; Kauczor HU; Delorme S
Ultrasound Med Biol; 2011 Nov; 37(11):1747-54. PubMed ID: 21963035
[TBL] [Abstract][Full Text] [Related]
8. A contrast-enhanced ultrasound study of benign and malignant breast tissue.
Barnard S; Leen E; Cooke T; Angerson W
S Afr Med J; 2008 May; 98(5):386-91. PubMed ID: 18637311
[TBL] [Abstract][Full Text] [Related]
9. Quantitative, noninvasive assessment of intra- and extraocular perfusion by contrast-enhanced ultrasonography and its clinical applicability in healthy dogs.
Blohm KO; Hittmair KM; Tichy A; Nell B
Vet Ophthalmol; 2019 Nov; 22(6):767-777. PubMed ID: 30773789
[TBL] [Abstract][Full Text] [Related]
10. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
Jung EM; Jung F; Stroszczynski C; Wiesinger I
Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of real-time contrast-enhanced ultrasonography in the differential diagnosis of breast tumor.
Wenhua D; Lijia L; Hui W; Wei Y; Li T
Cell Biochem Biophys; 2012 Jun; 63(2):117-20. PubMed ID: 22373958
[TBL] [Abstract][Full Text] [Related]
12. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Treatment of Malignant Liver Lesions: Evaluation of Success Using Contrast- Enhanced Ultrasound (CEUS) and Perfusion Software.
Wiesinger I; Wiggermann P; Zausig N; Beyer LP; Salzberger B; Stroszczynski C; Jung EM
Ultraschall Med; 2018 Aug; 39(4):440-447. PubMed ID: 28946152
[TBL] [Abstract][Full Text] [Related]
14. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions.
Du J; Li FH; Fang H; Xia JG; Zhu CX
J Ultrasound Med; 2008 Jun; 27(6):821-31. PubMed ID: 18499842
[TBL] [Abstract][Full Text] [Related]
15. [Value of contrast-enhanced sonography in early diagnosis of breast cancer].
Cai L; Zhang J; Song G; Chen L; Dai J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1801-5. PubMed ID: 24369249
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficacy of contrast-enhanced sonography by combined qualitative and quantitative analysis in breast lesions: a comparative study with magnetic resonance imaging.
Wang L; Du J; Li FH; Fang H; Hua J; Wan CF
J Ultrasound Med; 2013 Oct; 32(10):1805-14. PubMed ID: 24065262
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis.
Wan C; Du J; Fang H; Li F; Wang L
Eur J Radiol; 2012 Apr; 81(4):e444-50. PubMed ID: 21612882
[TBL] [Abstract][Full Text] [Related]
18. [Distinguishing benign and malignant lesions with time-signal intensity curve of dynamic contrast-enhanced breast MRI scanning].
Yuan HM; Yu JQ; Chu ZG; Peng LQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):556-9. PubMed ID: 21866648
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Malignant and Benign Orbital Space-Occupying Lesions Using Contrast-Enhanced Ultrasound: Added Value From a Time-Intensity Curve-Based Quantitative Analysis.
Zhang Y; Deng Q; Sun B; Chen L; Huang X; Pan J; Huang X; Zhang J; Chen W
J Ultrasound Med; 2021 Nov; 40(11):2477-2486. PubMed ID: 33470432
[TBL] [Abstract][Full Text] [Related]
20. Comparison of transducers with different frequencies in breast contrast-enhanced ultrasound (CEUS) using SonoVue as contrast agent.
Wang YM; Fan W; Zhang K; Zhang L; Tan Z; Ma R
Br J Radiol; 2016 Jul; 89(1063):20151050. PubMed ID: 27143439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
